Exeporfinium Chloride

依塞泊芬氯铵

Report date: 2026/03/29 20:00:13
NMEQIDP

Base Information

Drug NameExeporfinium Chloride
Drug Alias Name依泊氯铵exeporfinii chloridumcloruro de exeporfinioXF-73
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionCell membrane permeability modulators
TargetsUpdating
Therapy Area/IndicationsMucositisSurgical Wound InfectionSkin Diseases, Infectious +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSerbiaGeorgia +[4
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDestiny Pharma
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMucositisSkin Diseases, InfectiousRespiratory Tract Infections
Inactive IndicationsSurgical Wound InfectionStaphylococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A